
### [MONDO:0018646](http://purl.obolibrary.org/obo/MONDO_0018646)
**Label:** sclerosing cholangitis (disease)

**Subclasses:** [MONDO:0018647](http://purl.obolibrary.org/obo/MONDO_0018647) (secondary sclerosing cholangitis), [MONDO:0013433](http://purl.obolibrary.org/obo/MONDO_0013433) (primary sclerosing cholangitis), [MONDO:0018645](http://purl.obolibrary.org/obo/MONDO_0018645) (IgG4-related sclerosing cholangitis), [MONDO:0011199](http://purl.obolibrary.org/obo/MONDO_0011199) (nephropathy, progressive tubulointerstitial, with cholestatic liver disease), [MONDO:0011874](http://purl.obolibrary.org/obo/MONDO_0011874) (neonatal ichthyosis-sclerosing cholangitis syndrome), [MONDO:0018816](http://purl.obolibrary.org/obo/MONDO_0018816) (isolated neonatal sclerosing cholangitis), 

**Mapped go classes:** [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier), [GO:0061772](http://purl.obolibrary.org/obo/GO_0061772) (drug transport across blood-nerve barrier), [GO:0016328](http://purl.obolibrary.org/obo/GO_0016328) (lateral plasma membrane), [GO:0008065](http://purl.obolibrary.org/obo/GO_0008065) (establishment of blood-nerve barrier), [GO:1903348](http://purl.obolibrary.org/obo/GO_1903348) (positive regulation of bicellular tight junction assembly), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005923](http://purl.obolibrary.org/obo/GO_0005923) (bicellular tight junction), [GO:0016338](http://purl.obolibrary.org/obo/GO_0016338) (calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0004129](http://purl.obolibrary.org/obo/GO_0004129) (cytochrome-c oxidase activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0070673](http://purl.obolibrary.org/obo/GO_0070673) (response to interleukin-18), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0070830](http://purl.obolibrary.org/obo/GO_0070830) (bicellular tight junction assembly), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0001618](http://purl.obolibrary.org/obo/GO_0001618) (virus receptor activity), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), 

**Class expressions from DL-Learner:**

- [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier) 54.17%
- [GO:0070830](http://purl.obolibrary.org/obo/GO_0070830) (bicellular tight junction assembly) 54.17%
- [GO:0061772](http://purl.obolibrary.org/obo/GO_0061772) (drug transport across blood-nerve barrier) 54.17%
- [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier) 54.17%
- [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin) 54.17%
- [GO:0016338](http://purl.obolibrary.org/obo/GO_0016338) (calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules) 54.17%
- [GO:0016328](http://purl.obolibrary.org/obo/GO_0016328) (lateral plasma membrane) 54.17%
- [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane) 54.17%
- [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane) 54.17%
- [GO:0008065](http://purl.obolibrary.org/obo/GO_0008065) (establishment of blood-nerve barrier) 54.17%
- Thing 52.22%
- [GO:0001885](http://purl.obolibrary.org/obo/GO_0001885) (endothelial cell development) 43.69%
- [GO:0061028](http://purl.obolibrary.org/obo/GO_0061028) (establishment of endothelial barrier) 39.52%
- [GO:0050891](http://purl.obolibrary.org/obo/GO_0050891) (multicellular organismal water homeostasis) 39.52%
- [GO:0061028](http://purl.obolibrary.org/obo/GO_0061028) (establishment of endothelial barrier) and ([GO:0000391](http://purl.obolibrary.org/obo/GO_0000391) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 39.52%


